In March 2025, the Zhu Yibing Art Center in Beijing will present a highly anticipated musical event—Zhu Yibing's Classic and Crossover Cello & Piano Concert. This extraordinary concert will transcend ...

Like other fund managers, Nathan Rawlins has been fielding calls from clients concerned about economic uncertainty amid tariff headlines, "wondering when the market environment will turn, if it'll ...

Agatha Christie’s classic mystery continues to enthrall. Chor Leoni adds power and harmony to popular bops. Chor Leoni's Popcappella in 2023. It’s St. Patrick’s themed, but it’s also an ...

Assess today's live Cello World Ltd (CELO) share price, performance and insights using our live NSE: CELO stock exchange data. Analyse the historical data and Cello World Ltd share price performance ...

Kotak Small Cap Fund (G) 166.47 25,49,768 1.01 Kotak Small Cap Fund - Direct (G) 166.47 25,49,768 1.01 Kotak Small Cap Fund - Direct (IDCW) 166.47 25,49,768 1.01 Canara Robeco Emerging Equities (G) ...

Bobby Deol aims to break away from being typecast in negative roles despite the success of 'Aashram'. Crediting Prakash Jha for changing perceptions, Deol appreciates the positive reception and ...

"But now again, I'm getting typecast a lot. I'm trying to break away from this image also. It's not that I want to play the main lead," Deol told PTI in an interview. The positive reception to his ...

Nvidia's stock saw the pressure build as Thursday's session wore on, resulting in its worst post-earnings performance in more than six years. The stock ended the day off 8.5%, which was its ...

RIO stock moved below its 200-day simple moving ... 2026 have undergone negative revisions as shown in the charts below. Image Source: Zacks Investment Research Image Source: Zacks Investment ...

Bloom Energy Corporation BE is expected to report an improvement in its top and bottom lines when it reports fourth-quarter 2024 results on Feb. 27, after market close. The Zacks Consensus ...

The stock trades at $11.00 a share, translating to an approximate market capitalization of $600 million. The company's commercial therapy is Hemgenix, which was approved by the FDA in November ...

Some previously unloved corners of the U.S. stock market have quietly emerged as top performers on the S&P 500 this year, reshaping Wall Street as nontech names have finally received long-awaited ...